George Perry to Biomarkers
This is a "connection" page, showing publications George Perry has written about Biomarkers.
Connection Strength
0.395
-
Iron·ic facts about dementia. J Neurol Neurosurg Psychiatry. 2018 05; 89(5):446-447.
Score: 0.086
-
The complexities of the pathology-pathogenesis relationship in Alzheimer disease. Biochem Pharmacol. 2014 Apr 15; 88(4):671-6.
Score: 0.065
-
Antimicrobial peptide ß-defensin-1 expression is upregulated in Alzheimer's brain. J Neuroinflammation. 2013 Oct 18; 10:127.
Score: 0.064
-
Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathol. 2005 Sep; 110(3):232-8.
Score: 0.036
-
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village. Ageing Res Rev. 2024 01; 93:102173.
Score: 0.032
-
Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis. PLoS One. 2023; 18(3):e0281784.
Score: 0.031
-
The Amyloid-ß Pathway in Alzheimer's Disease. Mol Psychiatry. 2021 10; 26(10):5481-5503.
Score: 0.027
-
Decreased salivary lactoferrin levels are specific to Alzheimer's disease. EBioMedicine. 2020 Jul; 57:102834.
Score: 0.025
-
Precision pharmacology for Alzheimer's disease. Pharmacol Res. 2018 04; 130:331-365.
Score: 0.022
-
Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis. 2002 Mar; 9(2):244-8.
Score: 0.007